BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 22818074)

  • 1. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
    Reynolds MR; Magnuson EA; Wang K; Thourani VH; Williams M; Zajarias A; Rihal CS; Brown DL; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Aug; 60(6):548-58. PubMed ID: 22818074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
    D'Onofrio A; Rizzoli G; Messina A; Alfieri O; Lorusso R; Salizzoni S; Glauber M; Di Bartolomeo R; Besola L; Rinaldi M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1065-70; discussion 1070-1. PubMed ID: 24021955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial.
    Svensson LG; Blackstone EH; Rajeswaran J; Brozzi N; Leon MB; Smith CR; Mack M; Miller DC; Moses JW; Tuzcu EM; Webb JG; Kapadia S; Fontana GP; Makkar RR; Brown DL; Block PC; Guyton RA; Thourani VH; Pichard AD; Bavaria JE; Herrmann HC; Williams MR; Babaliaros V; Généreux P; Akin JJ;
    J Am Coll Cardiol; 2014 Jul; 64(2):158-68. PubMed ID: 25011720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial.
    Miller DC; Blackstone EH; Mack MJ; Svensson LG; Kodali SK; Kapadia S; Rajeswaran J; Anderson WN; Moses JW; Tuzcu EM; Webb JG; Leon MB; Smith CR; ;
    J Thorac Cardiovasc Surg; 2012 Apr; 143(4):832-843.e13. PubMed ID: 22424519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis.
    Humphries KH; Toggweiler S; Rodés-Cabau J; Nombela-Franco L; Dumont E; Wood DA; Willson AB; Binder RK; Freeman M; Lee MK; Gao M; Izadnegahdar M; Ye J; Cheung A; Webb JG
    J Am Coll Cardiol; 2012 Sep; 60(10):882-6. PubMed ID: 22818068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study.
    Latib A; Maisano F; Bertoldi L; Giacomini A; Shannon J; Cioni M; Ielasi A; Figini F; Tagaki K; Franco A; Covello RD; Grimaldi A; Spagnolo P; Buchannan GL; Carlino M; Chieffo A; Montorfano M; Alfieri O; Colombo A
    Am Heart J; 2012 Dec; 164(6):910-7. PubMed ID: 23194492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Baron SJ; Magnuson EA; Lu M; Wang K; Chinnakondepalli K; Mack M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Babaliaros V; Williams MR; Kereiakes D; Zajarias A; Alu MC; Webb JG; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2019 Dec; 74(23):2833-2842. PubMed ID: 31577923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons.
    Makkar RR; Jilaihawi H; Mack M; Chakravarty T; Cohen DJ; Cheng W; Fontana GP; Bavaria JE; Thourani VH; Herrmann HC; Pichard A; Kapadia S; Babaliaros V; Whisenant BK; Kodali SK; Williams M; Trento A; Smith CR; Teirstein PS; Cohen MG; Xu K; Tuzcu EM; Webb JG; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(9):901-11. PubMed ID: 24161334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.